Special articlePredicting creatinine clearance and renal drug clearance in obese patients from estimated fat-free body mass☆
References (36)
Pharmacokinetics in renal disease
Am J Med
(1977)- et al.
Dietary obesity in rats: body weight and body fat accretion in seven strains of rats
J Nutr
(1970) - et al.
Pharmacokinetics of tritiated water in normal and dietary-induced obese rats
J Pharmacol Methods
(1986) - et al.
Determination of serum creatinine by a direct colormetric method
Clin Chim Acta
(1973) - et al.
A computer program for estimation of creatinine clearance from unstable serum creatinine levels, age, sex, and weight
Math Biosci
(1972) - et al.
Fitting straight lines when both variables are subject to error
Life Sci
(1978) - et al.
Digoxin disposition in obesity: clinical pharmacokinetic investigation
Am Heart J
(1981) Drug dosage in patients with renal disease
Clin Pharmacol Ther
(1974)- et al.
Clinical estimation of creatinine clearance
Am J Clin Pathol
(1979) - et al.
Estimating creatinine clearance in morbidly obese patients
Am J Hosp Pharm
(1981)
Drug disposition in obese humans—an update
Clin Pharmacokinet
(1986)
An overfed rat model that reproduces acetaminophen disposition in obese humans
Drug Metab Dispos
(1986)
In vivo determination of body composition by tritium dilution in the rat
Br J Nutr
(1979)
Quetelet's index (W/H2) as a measure of fatness
Int J Obes
(1985)
Rapid evaluation of creatinine clearance
Acta Med Scand
(1974)
Prediction of creatinine clearance from serum creatinine
Nephron
(1976)
Vancomycin pharmacokinetics in normal and morbidly obese subjects
Antimicrob Agents Chemother
(1982)
Cimetidine clearance in the obese
Clin Pharmacol Ther
(1985)
Cited by (228)
Dose, dosage regimen, and dose adjustment in organ failure
2021, Biopharmaceutics and Pharmacokinetics Considerations: Volume 1 in Advances in Pharmaceutical Product Development and ResearchHow do i manage the morbidly obese critically ill patient?
2019, Evidence-Based Practice of Critical CareLongitudinal assessment of renal function in native kidney after bariatric surgery
2018, Surgery for Obesity and Related DiseasesUltrasound- and biomarker-based assessment of hepatic steatosis in patients with severe obesity
2023, Polish Archives of Internal MedicineDofetilide Dose Reductions and Discontinuation in Obese Compared with Nonobese Patients
2022, Journal of Cardiovascular Pharmacology
- ☆
This work was supported in part by Grant GM-20852 from the National Institutes of General Medical Sciences, National Institutes of Health.
Copyright © 1988 Published by Excerpta Medica Inc.